We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Rystiggo
Australian Public Assessment Report
Device/Product Name
Rystiggo
Active ingredients
rozanolixizumab
AusPAR Date
Published
Submission Number
PM-2023-04561-1-1
Submission Type
New biological entity
Decision
Approved